<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Dynavax Technologies Corporation

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Dynavax Technologies Corporation

    Dynavax Technologies Corporation (Nasdaq: DVAX) is a clinical-stage biopharmaceutical company with multiple product candidates in development for the prevention of infectious disease, the treatment of autoimmune and inflammatory diseases, and the treatment of cancer. We develop immunotherapies based on cutting-edge Toll-Like Receptor (TLR) biology and its ability to modulate the immune system. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Robert L. Coffman, PhD
    • FOUNDED
      1996
    • EMPLOYEES
      101-250
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Systec & Solutions GmbH

    Systec & Solutions GmbH

    Systec & Solutions GmbH, with headquarters in Karlsruhe (Germany), is a specialize...

    Systec & Solutions GmbH, with headquarters in K...

    Filing Type:    PR
    Surgery Partners, Inc.

    Surgery Partners, Inc.

    Headquartered in Nashville, Tennessee, Surgery Partners is a leading healthcare se...

    Headquartered in Nashville, Tennessee, Surgery ...

    Filing Type:    PU
    Orgenesis Inc.

    Orgenesis Inc.

    Orgenesis is a vertically-integrated biopharmaceutical company with unique experti...

    Orgenesis is a vertically-integrated biopharmac...

    Filing Type:    PU
    Alnylam Pharmaceuticals, Inc.

    Alnylam Pharmaceuticals, Inc.

    Alnylam is leading the translation of RNA interference (RNAi) into a whole new cla...

    Alnylam is leading the translation of RNA inter...

    Filing Type:    PU
    Advaxis, Inc.

    Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of ca...

    Advaxis was founded on the vision that no one s...

    Filing Type:    PU
    VBI Vaccines, Inc.

    VBI Vaccines, Inc.

    VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company d...

    VBI Vaccines Inc. (Nasdaq: VBIV) is a commercia...

    Filing Type:    PU
    Celgene Corporation

    Celgene Corporation

    Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global ...

    Celgene Corporation, headquartered in Summit, N...

    Filing Type:    PU
    Advaxis, Inc.

    Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of ca...

    Advaxis was founded on the vision that no one s...

    Filing Type:    PU
    Tiziana Life Sciences plc

    Tiziana Life Sciences plc

    Tiziana Life Sciences is a dual-listed (NASDAQ:TLSA, AIM:TILS) clinical stage biot...

    Tiziana Life Sciences is a dual-listed (NASDAQ:...

    Filing Type:    PU
    Momenta Pharmaceuticals, Inc.

    Momenta Pharmaceuticals, Inc.

    Momenta Pharmaceuticals is a biotechnology company specializing in the detailed st...

    Momenta Pharmaceuticals is a biotechnology comp...

    Filing Type:    PU
    Provention Bio, Inc.

    Provention Bio, Inc.

    Provention Bio, Inc. is a clinical-stage biopharmaceutical company developing nove...

    Provention Bio, Inc. is a clinical-stage biopha...

    Filing Type:    PU
    Immutep Limited

    Immutep Limited

    We are a biotechnology company developing novel immunotherapy treatments for cance...

    We are a biotechnology company developing novel...

    Filing Type:    PU
    Kiniksa Pharmaceuticals, Ltd.

    Kiniksa Pharmaceuticals, Ltd.

    We are a biopharmaceutical company focused on discovering, acquiring, developing a...

    We are a biopharmaceutical company focused on d...

    Filing Type:    PU
    Akari Therapeutics Plc

    Akari Therapeutics Plc

    Akari is a biopharmaceutical company focused on developing inhibitors of acute and...

    Akari is a biopharmaceutical company focused on...

    Filing Type:    PU
    Exicure, Inc.

    Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of ...

    Exicure, Inc. is a clinical stage biotechnology...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.